Policymakers on both ends of the political spectrum have been looking for ways to reduce prescription drug prices. Democrats have also been working on expanding healthcare coverage, including different versions of Medicare for All. All these proposals have been framed as issues of access and...

Drug recalls, contamination events, and shortages are on the rise, but drug companies still rely on decades-old manufacturing plants and processes. Contrary to widespread perceptions, drug manufacturing is typically expensive, inefficient, and non-innovative. Drug companies spend much more on...

This paper discusses how to improve Canada’s business innovation in order to boost labour productivity and output growth. Many general framework conditions are highly favourable to business risk-taking and innovation, including macro stability, openness, strong human capital, low corporate tax...

We study how the outputs of research spill over technological and geographic space in the context of the U.S. Small Business Innovation Research program. We infer input-output links using text analyses and identify the marginal costs of producing patents using noncompetitive grant matching...

This paper examines the location of foreign research and development (Ramp;D) establishments in China and reveals that such facilities are overly concentrated in Shanghai and Beijing, the two first-tier cities. We argue that the spatial concentration of Ramp;D in Shanghai and Beijing is more...

Since the 1980s, the US has experienced a surge in patenting and R&D. To better understand the phenomena, we explore the evolution of the market value of knowledge capital with a novel firm-level dataset. While the importance of R&D has steadily declined, the market value of patents made a large...

This paper examines how strategic alliances to create and use standards affect economic growth and development. The explanation of the link from standards to economic growth and development is through the effects of standards on the incentives to perform industrial research and development...

Although the use of patent indicators in statistics has been under discussion for a long time, there are surprisingly very few studies devoted to explaining the use of patent indicators as performance indicators in performance-based research funding systems. The widespread assumption is based on...

The patent system gives the courts discretion to tailor patentability standards flexibly across technologies to provide optimal incentives for innovation. For chemical inventions, the courts deem them unpatentable if the chemical lacks a practical, non-research-based use at the time patent...

Strategic patenting is widely believed to raise the costs of innovating, especially in industries characterised by cumulative innovation. This paper studies the effects of strategic patenting on Ramp;D, patenting and market value in the computer software industry. We focus on two key aspects:...